For years, scientists have tried to understand why children with Duchenne muscular dystrophy experience severe muscle wasting and eventual death. After all, laboratory mice with the same mutation that causes the disease in humans display only a slight weakness…
No Comments »
Filed under: Men's Health
WASHINGTON (MedPage Today) — Congress passed a year-long doctor payment fix this week, and an FDA advisory panel endorsed what could become the first new pharmaceutical option in weight loss in a decade.
No Comments »
Filed under: General Health News
13 million packages of Rolaids soft chews, over-the-counter antacid medications were recalled by Johnson & Johnson because consumers reported there were wood and metal particles within the products. McNeil Consumer Healthcare, part of Johnson & Johnson, assures that the chances of any serious health consequences for those who have bought these products is extremely “remote”…
No Comments »
Filed under: Pharmacy News
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced the initiation of dosing in a Phase 1 clinical trial of APD811, a novel oral drug candidate discovered by Arena that targets the prostacyclin receptor for the treatment of pulmonary arterial hypertension, or PAH…
No Comments »
Filed under: Pharmacy News
Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, announces results from two preclinical studies on entinostat, an orally bioavailable, highly selective, class I histone deacetylase (HDAC) inhibitor, in animal models of breast cancer…
No Comments »
Filed under: Pharmacy News
bioTheranostics, a bioMerieux company that develops innovative oncology diagnostic tests to support targeted disease management, announced new findings from a clinical study evaluating the company’s Breast Cancer Index (BCI) molecular oncology test. Data from the study were presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS)…
No Comments »
Filed under: Pharmacy News
Amgen (Nasdaq: AMGN) announced results from new analyses comparing XGEVA™ (denosumab), the first new treatment for advanced cancer patients with bone metastases in nearly a decade to prevent skeletal-related events, to Zometa® (zoledronic acid)…
No Comments »
Filed under: Pharmacy News
Voters would rather reduce Medicaid spending by better managing pharmacy benefits rather than cutting benefits for patients or payments to doctors and hospitals, according to a new poll commissioned by the Pharmaceutical Care Management Association (PCMA)…
No Comments »
Filed under: Pharmacy News
